This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

8 May 2020



Indian Immunologicals Limited, in collaboaration with Griffith University, Australia is going to commence research for developing a vaccine for Corona virus, the pandemic which has infected more than two million and killed about 250,00 people across the world. 

Even WHO has considered the same in its latest draft landscape of COVID 19 vaccine candidates dated 30th April, 2020.

Speaking on the development, Dr K Anand Kumar, Managing Director, Indian Immunologicals Limited said, “IIL is committed to addressing critical public health needs by engaging in this research collaboration. The mission at IIL is to develop and supply vaccines that support the One Health initiative. IIL has taken up this initiative to develop a vaccine candidate for the pandemic- COVID 19

IIL’s leadership in producing safe and affordable human and veterinary vaccines will enable us to progress well in this endeavor".

Mentioned Companies
Indian Immunologicals Ltd
View company profile